Smoking History as a Predictive Factor of Treatment Response in Advanced Non-Small-Cell Lung Cancer: A Systematic Review

Grants

Funding Acknowledgements

This systematic review was sponsored by Eli Lilly and Company. In compliance with the Uniform Requirements for Manuscripts, established by the International Committee of Medical Journal Editors, Eli Lilly and Company did not impose any impediment, directly or indirectly, on the conduct of the review, the interpretation of the results, or the preparation of this manuscript. Rebecca Lew was paid for her services as a medical writer by a financial grant from Eli Lilly and Company.